Clinical Experience With Infliximab Therapy in 100 Patients With Crohn's Disease

A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's Disease

1997 • 3,152 citations

A SIMPLE INDEX OF CROHN'S-DISEASE ACTIVITY

1980 • 2,735 citations

Infliximab for the Treatment of Fistulas in Patients with Crohn's Disease

1999 • 2,656 citations

Efficacy and safety of retreatment with anti–tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease

1999 • 1,107 citations

Tumour necrosis factor and Crohn's disease.

1997 • 504 citations

Antitumor Necrosis Factor Therapy for Inflammatory Bowel Disease: A Review of Agents, Pharmacology, Clinical Results, and Safety

1999 • 459 citations

Usual therapy improves perianal Crohn's disease as measured by a new disease activity index. McMaster IBD Study Group.

1995 • 300 citations

Usual Therapy Improves Perianal Crohn??s Disease as Measured by a New Disease Activity Index

1995 • 287 citations

Chronic exposure to tumor necrosis factor (TNF) in vitro impairs the activation of T cells through the T cell receptor/CD3 complex; reversal in vivo by anti-TNF antibodies in patients with rheumatoid arthritis.

1994 • 253 citations

Therapy of inflammatory bowel disease

2000 • 248 citations

Infliximab in Crohn's Disease: First Anniversary Clinical Experience

2000 • 238 citations

Anti-Tumor Necrosis Factor-α Therapy of Rheumatoid Arthritis

1997 • 233 citations

Budesonide versus prednisone in the treatment of active Crohn's disease

1998 • 220 citations

A randomized, double-blind, placebo-controlled, multi-center trial of the engineered human anti body to TNF (CDP571) for steroid sparing and maintenance of remission in patients with steroid-dependent Crohn's disease

2000 • 78 citations

Intravenous cyclosporin in ulcerative colitis: a five-year experience

1999 • 26 citations